First Header Logo Second Header Logo

Connection

Joseph Rigdon to Sirolimus

Back to Details
This is a "connection" page, showing publications Joseph Rigdon has written about Sirolimus.
Joseph Rigdon
Connection Strength
0.040
Sirolimus
  1. Sang AX, McPherson MC, Ivison GT, Qu X, Rigdon J, Esquivel CO, Krams SM, Martinez OM. Dual blockade of the PI3K/Akt/mTOR pathway inhibits posttransplant Epstein-Barr virus B cell lymphomas and promotes allograft survival. Am J Transplant. 2019 05; 19(5):1305-1314.
    View in: PubMed
    Score: 0.040
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.